PATIENT CONCERNS OVER MANUFACTURER-OWNED PBMs PERSIST, GM's WHITEHOUSE TELLS NACDS; BAY AREA BUSINESS GROUP EXPLORING STANDARD FORMULARY
General Motors is aware of employees' concerns about Merck's ownership of its pharmacy benefit administrator Medco, GM National Managed Pharmacy Program Manager Janet Whitehouse remarked at the National Association of Chain Drug Stores managed pharmacy conference in Boston Aug. 25.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth